- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
GeneReach Biotechnology (4171)
GeneReach Biotechnology stock price live, this page displays TWO 4171 stock exchange data. View the 4171 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the GeneReach Biotechnology real time stock price chart below.
What Is the GeneReach Biotechnology Stock Price Today?
The GeneReach Biotechnology stock price today is 19.90.
What Is the Stock Symbol for GeneReach Biotechnology?
The stock symbol for GeneReach Biotechnology is ""4171.""
What Stock Exchange Does GeneReach Biotechnology Trade On?
GeneReach Biotechnology is listed and trades on the TPEX stock exchange.
Is GeneReach Biotechnology a Good Stock to Buy?
Determining whether GeneReach Biotechnology—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4171 quote. (ISIN: TW0004171004)
What Is the GeneReach Biotechnology Stock Price Today?
The GeneReach Biotechnology stock price today is 19.90.
What Is the Stock Symbol for GeneReach Biotechnology?
The stock symbol for GeneReach Biotechnology is ""4171.""
What Stock Exchange Does GeneReach Biotechnology Trade On?
GeneReach Biotechnology is listed and trades on the TPEX stock exchange.
Is GeneReach Biotechnology a Good Stock to Buy?
Determining whether GeneReach Biotechnology—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4171 quote. (ISIN: TW0004171004)
TPEX
Currency in TWD
19.90
0.00(0.00%)
Closed·
Fair Value
An estimate of a GeneReach BioTech's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
19.65
20.00
52 wk Range
15.40
34.90
4171 Scorecard
Full Analysis
Management has been aggressively buying back shares
Earnings results expected today
1/2
Fair Value
An estimate of a GeneReach BioTech's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
19.6520.00
52 wk Range
15.4034.90
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
4171 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a GeneReach BioTech's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Holds more cash than debt on its balance sheet
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
GeneReach Biotechnology Company Profile
GeneReach Biotechnology Corp. develops, manufactures, and markets products for applied nucleic acid detection technology in Taiwan. The company offers automatic nucleic acid extraction systems, prep homogenization system, and mini centrifuge equipment; and reagents and consumables, comprising human IVD assays, iiPCR specific reagents, taco nucleic acid extraction reagents, IQ real quantitative systems, IQ2000 detection and prevention systems, and research reagents and consumables. It also provides polymerase chain reaction training programs (PCR), molecular diagnostic technical solutions, laboratory installation services, OEM/ODM contract manufacturing services, and research collaboration services. It serves aquaculture, agriculture, food, and human health industries, as well as companion animals and livestock. The company was founded in 2004 and is headquartered in Taichung, Taiwan.
Compare 4171 to Peers and Sector
Metrics to compare | 4171 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship4171PeersSector | |
|---|---|---|---|---|
P/E Ratio | −8.2x | −143.1x | −0.5x | |
PEG Ratio | −37.07 | −1.76 | 0.00 | |
Price/Book | 1.9x | 6.5x | 2.6x | |
Price / LTM Sales | 5.1x | 9.1x | 3.3x | |
Upside (Analyst Target) | - | 0.0% | 38.7% | |
Fair Value Upside | Unlock | −14.2% | 5.0% | Unlock |
Earnings
Latest Release
Aug 27, 2025
EPS / Forecast
-1.16 / --
Revenue / Forecast
54.50M / --
FAQ
What Stock Exchange Does GeneReach BioTech Trade On?
GeneReach BioTech is listed and trades on the Taipei Exchange stock exchange.
What Is the Stock Symbol for GeneReach BioTech?
The stock symbol for GeneReach BioTech is "4171."
What Is the GeneReach BioTech Market Cap?
As of today, GeneReach BioTech market cap is 1.14B.
What Is GeneReach BioTech's Earnings Per Share (TTM)?
The GeneReach BioTech EPS (TTM) is -2.42.
When Is the Next GeneReach BioTech Earnings Date?
GeneReach BioTech will release its next earnings report on 26 Aug 2025.
From a Technical Analysis Perspective, Is 4171 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has GeneReach BioTech Stock Split?
GeneReach BioTech has split 4 times.
How Many Employees Does GeneReach BioTech Have?
GeneReach BioTech has 0 employees.
What is the current trading status of GeneReach BioTech (4171)?
As of 27 Aug 2025, GeneReach BioTech (4171) is trading at a price of 19.90, with a previous close of 23.10. The stock has fluctuated within a day range of 19.65 to 20.00, while its 52-week range spans from 15.40 to 34.90.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.